Jack Steele is the Chief Operating Officer of Protomer Technologies, a wholly owned subsidiary of Eli Lilly and Company, where they have played a crucial role since joining as the first employee in 2016. A graduate with honors in Neuroscience from UCLA, they contributed significantly to the development of innovative protein therapeutics, including glucose-responsive insulins. Jack's expertise was instrumental in guiding the company through its acquisition by Eli Lilly in 2021, and they currently oversee the expanding R&D operations of Protomer. Earlier in their career, Jack gained valuable experience as a Research Intern at HMRI and as a Wasserman Research Fellow at the Eli & Edythe Broad Center for Regenerative Medicine & Stem Cell Research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices